Q3 revenue increases 42% YoY to US$25.1 million
Building out CPG infrastructure ahead of FDA
regulatory growth catalyst
BOULDER, CO, Nov. 13, 2019 /PRNewswire/ - (TSX:CWEB,
OTCQX:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or
the "Company") the market share leader in full spectrum cannabidiol
(CBD) hemp extract products, today reported financial results for
the third quarter ended September 30,
2019. All amounts are expressed in United States dollars. Certain metrics,
including those expressed on an adjusted basis, are non-IFRS
measures.
Third Quarter 2019 Financial Highlights
- Organic consolidated year-over-year revenue growth of 41.8% to
$25.1 million
- B2C ecommerce sales increased 38.7%, B2B retail sales increased
66.4%
- Gross margin of 71.3% (before biological asset adjustments)
produced gross profit of $17.9
million
- Increased operational investments in preparation of FDM channel
growth
- Increased investment into expand production, distribution
R&D and extraction capacity
- Adjusted EBITDA $0.7 million,
2.8% of consolidated revenue reflecting infrastructure build
- $35M cash and $96M working capital
Third Quarter 2019 Business Highlights
- Surpassed 9,000 doors carrying Charlotte's Web™ products
- Expanded into new states and locations with current and new
retail partners
- Increased retail breadth and product depth with new CBD oil
flavors, pet and gummy SKUs
- Evolved CPG leadership team and commenced buildout of
infrastructure to expand production, distribution, R&D and
extraction capacity processes ahead of the anticipated mass retail
channel growth
- New 136,610 sq ft facility expected to increase current
capacity by 10X with significant future operational and production
cost savings through higher efficiencies by Q3 2020
- Executed additional actions to support regulatory progress at
the federal and state levels
"In an increasingly crowded, noisy and confusing CBD market,
brands matter, and Charlotte's Web is the most trusted hemp extract
in the world," said Deanie Elsner,
Chief Executive Officer of Charlotte's Web. "Consumers are becoming
more informed about product ingredients, production quality, and
variances between CBD isolate and full spectrum hemp extract
efficacy. Consumer education is increasing and a 68% year-over-year
increase in traffic through our online store drove Q3 B2C sales to
new highs. As the CBD category's flagship brand, we saw a similar
66% increase in sales pull into our B2B segment which includes the
food/drug/mass ("FDM") and natural health retail channels. This
helped drive Q3 growth to 42% year-over-year. The majority of our
FDM channel partners to only sell CBD topicals while awaiting legal
and regulatory clarity from the U.S. Food and Drug Association
("FDA"). Topicals account for less than 15% of our sales at
independent stores that carry both our topical and ingestible CBD
product lines. This indicates the potential revenue catalyst of a
broad adoption of ingestible products within the FDM channel. We
are prudently investing in the expansion of our production and
distribution capacities as planned, ahead of anticipated FDA
regulatory clarity that could enable wider adoption of our product
portfolio. We remain hopeful that broad political support will help
drive quick regulatory resolutions in 2020."
Ms. Elsner updated the Company's revenue guidance: "We're
pleased with our growth of 42% for Q3 and 49.6% year-to-date. We
expect full year revenue for 2019 to be in the range of
$95 to $100
million and to maintain growth rates for 2020 in the 40% to
50% range or until clear regulations are set."
Business Review
In the third quarter Kroger Co., America's largest grocery
retailer, expanded distribution of Charlotte's Web products into
five new states for a total of 22 states and 1,350 store locations.
Subsequent to the quarter, Kroger has further expanded the
distribution increasing the total to 1,497 locations. Vitamin
Shoppe, an omni-channel specialty retailer of nutritional products,
commenced selling the new line of Charlotte's Web CBD gummies in
738 stores across 45 states in Q3. Combined, Charlotte's
Web's largest FDM retail partners expanded by 787 locations selling
product during the quarter. In addition, several smaller regional
chains began selling Charlotte's Web products through a combined
total of 296 new doors.
Early sales traction for the new 12 SKU pet line from
Charlotte's Web has been encouraging with a 57% year-over-year
increase in revenue with notable success in the independent retail
channel. The new pet line includes functionally focused chews with
synergistic ingredients to support specific health functions -
Calming, Hips & Joints and Cognition. Two pet food and
pet products distribution partners were also added during the
quarter covering more than 5,000 potential retail customers.
The impact from the traditional mass retail channel's entrance
into the CBD category in 2019 will influence suppliers to function
like CPG manufacturing organizations in order to succeed. To help
lead this transition at Charlotte's Web, top tier CPG management
was added to the leadership team, including Russ Hammer as Chief Financial Officer,
Tony True as Chief Customer Officer,
and Paul Lanham as Chief Information
Officer.
The Company is investing to expand production, distribution,
R&D and extraction capacity, with the signing of a building
lease on a newly constructed 136,610 square-foot industrial
building located at 700 Tech Court in the Colorado Technology
Center (CTC) in Louisville,
Colorado. The new location enables to Company to prepare for
increased demand from the mass consumer retail channels. The
capacity gains from this facility are expected to support more than
ten times the current production capacity and deliver significant
production and distribution cost savings.
Financial Review
Financial Summary for the three and nine months ended
September 30, 2019:
|
|
Three months
ended
|
|
Nine months
ended
|
|
|
September
30,
|
|
September
30,
|
U.S. $ millions,
except per share data
|
|
2019
|
|
2018
|
|
2019
|
|
2018
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
$
|
25.1
|
|
$
|
17.7
|
|
$
|
71.8
|
|
$
|
48.0
|
Gross profit before
biological assets
adjustment
|
|
$
|
17.9
|
|
$
|
13.8
|
|
$
|
52.2
|
|
$
|
37.1
|
Net impact, fair
value of biological
assets
|
|
$
|
-
|
|
$
|
1.5
|
|
$
|
(0.5)
|
|
$
|
1.0
|
Gross
profit
|
|
$
|
17.9
|
|
$
|
12.3
|
|
$
|
52.7
|
|
$
|
36.0
|
Operating
expenses
|
|
$
|
19.6
|
|
$
|
9.8
|
|
$
|
49.1
|
|
$
|
24.4
|
Other (income) and
expense, net
|
|
$
|
(0.2)
|
|
$
|
(0.3)
|
|
$
|
(0.7)
|
|
$
|
(0.2)
|
Income (loss) before
taxes
|
|
$
|
(1.6)
|
|
$
|
2.8
|
|
$
|
4.3
|
|
$
|
11.9
|
Net income
(loss)
|
|
$
|
(1.3)
|
|
$
|
1.8
|
|
$
|
3.2
|
|
$
|
8.7
|
EPS
basic
|
|
$
|
(0.01)
|
|
$
|
0.02
|
|
$
|
0.03
|
|
$
|
0.11
|
EPS
diluted
|
|
$
|
(0.01)
|
|
$
|
0.02
|
|
$
|
0.03
|
|
$
|
0.10
|
Adjusted
EBITDA
|
|
$
|
0.7
|
|
$
|
5.3
|
|
$
|
8.5
|
|
$
|
16.0
|
|
|
|
|
|
|
|
|
|
Assets:
|
|
Sep 30,
2019
|
|
Jun 30,
2019
|
|
Mar 31,
2019
|
|
Dec 31,
2018
|
Cash and cash
equivalents
|
|
$
|
35.0
|
|
$
|
51.4
|
|
$
|
69.1
|
|
$
|
73.4
|
Total
assets
|
|
$
|
181.0
|
|
$
|
157.2
|
|
$
|
171.7
|
|
$
|
139.1
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
Long-term
liabilities
|
|
$
|
28.3
|
|
$
|
8.3
|
|
$
|
4.6
|
|
$
|
3.5
|
Total
liabilities
|
|
$
|
51.9
|
|
$
|
22.3
|
|
$
|
20.1
|
|
$
|
17.6
|
Quarterly revenue growth for the Company's nine most recent
fiscal quarters:
|
Q3
|
Q2
|
Q1
|
Q4
|
Q3
|
Q2
|
Q1
|
Q4
|
Q3
|
U.S. $
millions
|
2019
|
2019
|
2019
|
2018
|
2018
|
2018
|
2018
|
2017
|
2017
|
Total
revenue
|
$
|
25.1
|
$
|
25.0
|
$
|
21.7
|
$
|
21.5
|
$
|
17.7
|
$
|
17.2
|
$
|
13.1
|
$
|
12.5
|
$
|
11.3
|
Revenue for the third quarter ended September 30, 2019 totaled $25.1 million, compared to $17.7 million for the same period in 2018,
representing a 41.8% increase. Human consumables, topicals and pet
products grew by 43.6%, 156.7% and 57.5%, respectively. On a
year-over-year basis for the quarter ended September 30, 2019, B2C sales grew by 38.7% and
accounted for 51.2% of total revenue in the quarter as online
traffic increased 68% through expanded marketing and social media
programs. B2B sales grew by 66.4% year-over-year and accounted for
48.8% of total revenue in the quarter as mass retailers including
Kroger Co., Vitamin Shoppe and CVS Pharmacy locations entered the
market in 2019.
Gross margin prior to biological asset adjustments was 71.3%,
compared to 78.0% for the same period in 2018. Gross profit totaled
$17.9 million for the quarter ended
September 30, 2019, compared to
$12.3 million for the same period in
2018, a year-over-year increase of 45.5%.
Third quarter operating expenses were $4.7 million, a year-over-year increase from
$2.4 million to support the Company's
growth and transition to a consumer-packaged goods operating
company. During the quarter the Company relocated into larger
office facilities in Boulder and
added senior CPG management to the leadership team along with
related personnel. Employee headcount was 307 at September 30, 2019, a 35.8% increase from 226 at
September 30, 2018.
Adjusted EBITDA for the third quarter was $0.7 million or 2.8% of consolidated revenue
compared to $5.3 million and 29.9% of
consolidated revenue for the third quarter of 2018. The lower
Adjusted EBITDA ratio during the third quarter reflects investment
in infrastructure and personnel as the Company builds its internal
capabilities to support expected future revenue growth from the FDM
channel.
The Company used $24.8 million of
cash in operations during the first nine months of 2019 compared to
$1.5 million of cash provided from
operations during the same period in 2018. Cash used in operations
during the first nine months of 2019 primarily reflects the
investment in planting, cultivation and inventory required to
supply increasing retail and consumer demand. Net cash of
$12.9 million used in investing
activities for the nine-month period was primarily for the purchase
of equipment, building and land used in the Company's cultivation
and manufacturing operations. At September 30, 2019 the Company held cash of
$35.0 million and working capital of
$95.9 million.
Ernst & Young LLP Appointed Auditors
During the quarter Charlotte's Web board of directors has
approved the appointment of Ernst & Young LLP ("EY") as the
Company's new auditor, replacing prior auditor, MNP LLP as the
Company continues its transition to a U.S. CPG manufacturing
company and U.S. stock exchange cross-listing in addition to its
current listing on the Toronto Stock Exchange.
The decision was made following an extensive and competitive
review involving a number of accounting firms, and was not the
result of any disagreement between the Company and MNP on any
matter of accounting principles or practices, financial statement
disclosure, or auditing scope or procedure.
"This appointment reflects the commitment of the Company and its
Board of Directors to continued strong corporate governance,
domestically and internationally," added Ms. Elsner.
The Notice of Change of Auditor, together with the required
letters from MNP and EY have been filed on sedar.com.
Consolidated Financial Statements and Management's Discussion
and Analysis
The Company's unaudited interim condensed financial statements
and accompanying notes for the periods ended September 30, 2019 and 2018 and related
management's discussion and analysis of financial condition and
results of operations ("MD&A") are available under the
Company's profile on SEDAR at www.sedar.com and on the Investor
Relations section of the Company's website at
https://investors.charlottesweb.com.
Conference Call
Management will host a conference call to discuss the Company's
third quarter 2019 results at 8:00 am ET on Wednesday, November 13, 2019. Charlotte's Web CEO
Deanie Elsner, CFO Russ Hammer and Director of Investor Relations
Cory Pala, will host the call,
followed by a question and answer period. To participate in the
call, please dial 1-647-427-7450 or 1-888-231-8191 approximately 10
minutes before the conference call. A recording of the
call will be available through November
20, 2019. To listen to a replay of the earnings call
please dial 1-416-849-0833 and provide conference ID
7899894.
A webcast of the call can be accessed through the investor
relations section of the Charlotte's Web website.
About Charlotte's Web Holdings, Inc.
Charlotte's Web Holdings, Inc. is the market leader in the
production and distribution of innovative hemp-based cannabidiol
("CBD") wellness products. Founded by the Stanley Brothers, the
Company's premium quality products start with proprietary hemp
genetics that are responsibly manufactured into whole-plant hemp
extracts naturally containing a full spectrum of phytocannabinoids,
including CBD, terpenes, flavonoids and other beneficial hemp
compounds. Charlotte's Web product categories include human
consumables (tinctures, capsules, and gummies, topicals, as well as
pet products. Charlotte's Web hemp-based whole plant extracts
are sold through select distributors, brick and mortar retailers,
and online through the Company's website at www.CharlottesWeb.com.
The rate the Company pays for agricultural products reflects a fair
and sustainable rate driving higher quality yield, encouraging good
farming practices, and supporting U.S. farming communities.
Charlotte's Web is a socially conscious company and is committed
to using business as a force for good and a catalyst for
innovation. The Company weighs sound business decisions with
consideration for how its efforts affect its employees, customers,
the environment, and the communities where its employees live and
where it does business, while maximizing profits and strengthening
its brands. The Company's management believes that socially
oriented actions have a positive impact on the Company, its
employees and its shareholders. Charlotte's Web donates a portion
of its pre-tax earnings to charitable organizations.
Shares of Charlotte's Web trade on the Toronto Stock Exchange
(TSX) under the symbol "CWEB" and are quoted in U.S. Dollars in
the United States on the OTCQX
under the symbol "CWBHF". As of November 12, 2019, Charlotte's Web had 57,046,941
Common Shares outstanding and 103,860.4775 Proportional Voting
Shares convertible at 400:1, for an effective equivalent of
98,591,132 Common Shares outstanding.
1.
|
Adjusted earnings
before interest, taxes, depreciation and amortization (Adjusted
EBITDA) is not a recognized performance measure under IFRS.
The term EBITDA consists of net income (loss) and excludes interest
(financing costs), taxes, depreciation and amortization. Adjusted
EBITDA also excludes share-based compensation, IPO related costs,
impairment of assets and adjustments for fair valuing of biological
assets. Adjusted EBITDA is included as a supplemental disclosure
because Management believes that such measurement provides a better
assessment of the Company's operations on a continuing basis by
eliminating certain non-cash charges and charges or gains that are
nonrecurring. The most directly comparable measure to Adjusted
EBITDA calculated in accordance with IFRS is net income
(loss).
|
Forward-Looking Information
This press release may contain forward-looking information
within the meaning of applicable securities legislation. In the
interest of providing the shareholders and potential investors of
Charlotte's Web Holdings, Inc. with information about the Company
and its subsidiaries, including management's assessment of the
Company and its subsidiaries' future plans and operations, certain
information provided in this press release constitutes
forward-looking statements or information (collectively,
"forward-looking statements"). Forward-looking statements are
typically identified by words such as "may", "will", "should",
"could", "anticipate", "expect", "project", "estimate", "forecast",
"plan", "intend", "target", "believe" and similar words suggesting
future outcomes or statements regarding an outlook. Although these
forward-looking statements are based on assumptions the Company
considers to be reasonable based on the information available on
the date such statements are made, such statements are not
guarantees of future performance and readers are cautioned against
placing undue reliance on forward-looking statements. By their
nature, these statements involve a variety of assumptions, known
and unknown risks and uncertainties, and other factors which may
cause actual results, levels of activity, and achievements to
differ materially from those expressed or implied by such
statements. The forward-looking information contained in this press
release is based on certain assumptions and analysis by management
of the Company in light of its experience and perception of
historical trends, current conditions and expected future
development and other factors that it believes are
appropriate.
The Company's forward-looking statements are subject to risks
and uncertainties pertaining to, among other things, revenue
fluctuations, nature of government regulations, economic
conditions, loss of key customers, retention and availability of
executive talent, competing products, common share price
volatility, loss of proprietary information, product acceptance,
internet and system infrastructure functionality, information
technology security, cash available to fund operations,
availability of capital and, international and political
considerations, including but not limited to those risks and
uncertainties discussed under the heading "Risk Factors" in the
MD&A and the Company's other filings with securities
regulators. The impact of any one risk, uncertainty, or factor on a
particular forward-looking statement is not determinable with
certainty as these are interdependent, and the Company's future
course of action depends on Management's assessment of all
information available at the relevant time. Except to the extent
required by law, the Company assumes no obligation to publicly
update or revise any forward-looking statements made in this press
release, whether as a result of new information, future events, or
otherwise. All subsequent forward-looking statements, whether
written or oral, attributable to the Company or persons acting on
the Company's behalf, are expressly qualified in their entirety by
these cautionary statements.
CHARLOTTE'S WEB
HOLDINGS, INC.
|
|
|
|
UNAUDITED INTERIM
CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
|
(In thousands of
United States dollars)
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30,
2019
|
|
December 31,
2018
|
ASSETS
|
|
|
|
|
|
|
|
Current
assets:
|
|
|
|
|
Cash
|
$
|
34,980
|
|
$
|
73,404
|
|
Trade and other
receivables, net
|
6,661
|
|
4,874
|
|
Note
receivable
|
1,400
|
|
-
|
|
Inventories
|
57,631
|
|
23,969
|
|
Prepaid expenses and
other current assets
|
15,337
|
|
3,917
|
|
Income taxes
receivable
|
3,464
|
|
1,787
|
|
|
119,473
|
|
107,951
|
Non-current
assets:
|
|
|
|
|
Property and
equipment, net
|
34,890
|
|
6,806
|
|
Intangibles
|
1,317
|
|
619
|
|
Deferred tax
assets
|
24,283
|
|
23,449
|
|
Loan due from related
parties
|
107
|
|
128
|
|
Other long-term
assets
|
913
|
|
181
|
|
|
$
|
180,983
|
|
$
|
139,134
|
|
|
|
|
|
LIABILITIES AND
SHAREHOLDERS' EQUITY
|
|
|
|
|
|
|
|
Current
liabilities:
|
|
|
|
|
Accounts
payable
|
$
|
4,075
|
|
$
|
3,379
|
|
Accrued
liabilities
|
16,182
|
|
10,014
|
|
Deferred
revenue
|
484
|
|
467
|
|
Current portion of
notes payable
|
9
|
|
9
|
|
Current portion of
lease obligations
|
2,799
|
|
283
|
|
|
23,549
|
|
14,152
|
Non-current
liabilities:
|
|
|
|
|
Long-term note
payable
|
5
|
|
12
|
|
Long-term lease
obligations
|
17,443
|
|
113
|
|
Deferred
rent
|
-
|
|
73
|
|
Other long-term
liabilities
|
10,885
|
|
3,286
|
|
|
51,882
|
|
17,636
|
Shareholders'
equity:
|
|
|
|
|
Share
capital
|
105,368
|
|
101,175
|
|
Contributed
surplus
|
2,697
|
|
2,498
|
|
Retained
earnings
|
21,036
|
|
17,825
|
|
|
129,101
|
|
121,498
|
|
|
|
|
|
|
|
$
|
180,983
|
|
$
|
139,134
|
CHARLOTTE'S WEB
HOLDINGS, INC.
|
|
|
|
UNAUDITED INTERIM
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) AND OTHER
COMPREHENSIVE INCOME (LOSS)
|
(In thousands of
United States dollars, except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
September 30,
|
Nine months ended
September 30,
|
|
|
2019
|
2018
|
2019
|
2018
|
|
|
|
|
|
|
Revenue
|
$
|
25,045
|
$
|
17,736
|
$
|
71,765
|
$
|
48,046
|
Cost of
sales
|
7,181
|
3,967
|
19,612
|
10,990
|
Gross profit before
loss on fair value of biological assets
|
17,864
|
13,769
|
52,153
|
37,056
|
Realized fair value
amounts included in inventory sold
|
(65)
|
(147)
|
(561)
|
(600)
|
Unrealized fair value
loss on growth of biological assets
|
48
|
1,622
|
48
|
1,622
|
Gross
profit
|
17,881
|
12,294
|
52,666
|
36,034
|
|
|
|
|
|
Expenses:
|
|
|
|
|
|
General and
administrative
|
13,064
|
5,272
|
30,585
|
14,252
|
|
Sales and
marketing
|
6,281
|
3,910
|
17,368
|
8,385
|
|
Research and
development
|
255
|
132
|
1,099
|
386
|
|
Initial public
offering related costs
|
-
|
473
|
-
|
1,332
|
|
|
19,600
|
9,787
|
49,052
|
24,355
|
Operating income
(loss)
|
(1,719)
|
2,507
|
3,614
|
11,679
|
|
Financing
costs
|
107
|
31
|
241
|
160
|
|
Interest
income
|
(187)
|
(138)
|
(853)
|
(191)
|
|
Other
income
|
(66)
|
(196)
|
(60)
|
(196)
|
Income (loss) before
taxes
|
(1,573)
|
2,810
|
4,286
|
11,906
|
|
Income tax expense
(benefit)
|
(259)
|
987
|
1,075
|
3,250
|
Net income (loss) and
comprehensive income (loss)
|
$
|
(1,314)
|
$
|
1,823
|
$
|
3,211
|
$
|
8,656
|
|
|
|
|
|
|
Weighted average
number of common shares - basic
|
97,486,347
|
83,472,950
|
95,244,686
|
80,792,665
|
Weighted average
number of common shares - diluted
|
106,124,170
|
91,501,078
|
106,206,202
|
86,937,632
|
|
|
|
|
|
|
Earnings (loss) per
share - basic
|
$
|
(0.01)
|
$
|
0.02
|
$
|
0.03
|
$
|
0.11
|
Earnings (loss) per
share - diluted
|
$
|
(0.01)
|
$
|
0.02
|
$
|
0.03
|
$
|
0.10
|
CHARLOTTE'S WEB
HOLDINGS, INC.
|
|
|
|
|
|
UNAUDITED INTERIM
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS'
EQUITY
|
(In thousands of
United States dollars)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine months ended
September 30, 2018
|
Share
capital
|
Contributed
surplus
|
Retained
earnings
|
Total
|
|
|
|
|
|
|
|
|
|
Balance - December
31, 2017
|
$
|
5,835
|
$
|
787
|
$
|
6,017
|
$
|
12,639
|
|
|
|
|
|
|
|
|
|
Initial Public
Offering
|
|
71,958
|
|
-
|
|
-
|
|
71,958
|
|
|
|
|
|
|
|
|
|
Private
Placement
|
|
4,256
|
|
-
|
|
-
|
|
4,256
|
|
|
|
|
|
|
|
|
|
Exercise of common
stock options
|
|
42
|
|
-
|
|
-
|
|
42
|
|
|
|
|
|
|
|
|
|
Issuance of broker
stock warrants
|
|
(845)
|
|
845
|
|
-
|
|
-
|
|
|
|
|
|
|
|
|
|
Exercise of broker
stock warrants
|
|
1,782
|
|
-
|
|
-
|
|
1,782
|
|
|
|
|
|
|
|
|
|
Share-based
compensation expense
|
|
-
|
|
639
|
|
-
|
|
639
|
|
|
|
|
|
|
|
|
|
Share issuance
costs
|
|
(3,806)
|
|
-
|
|
-
|
|
(3,806)
|
|
|
|
|
|
|
|
|
|
Net income
|
|
-
|
|
-
|
|
8,656
|
|
8,656
|
|
|
|
|
|
|
|
|
|
Balance - September
30, 2018
|
$
|
79,222
|
$
|
2,271
|
$
|
14,673
|
$
|
96,166
|
|
|
|
|
|
|
|
|
|
Nine months ended
September 30, 2019
|
Share
capital
|
Contributed
surplus
|
Retained
earnings
|
Total
|
|
|
|
|
|
|
|
|
|
Balance - December
31, 2018
|
$
|
101,175
|
$
|
2,498
|
$
|
17,825
|
$
|
121,498
|
|
|
|
|
|
|
|
|
|
Exercise of common
stock options
|
|
963
|
|
(268)
|
|
-
|
|
695
|
|
|
|
|
|
|
|
|
|
Exercise of broker
stock warrants
|
|
1,328
|
|
(842)
|
|
-
|
|
486
|
|
|
|
|
|
|
|
|
|
Income tax benefit
from stock options
|
|
1,902
|
|
-
|
|
-
|
|
1,902
|
|
|
|
|
|
|
|
|
|
Share-based
compensation expense
|
|
-
|
|
1,309
|
|
-
|
|
1,309
|
|
|
|
|
|
|
|
|
|
Net income
|
|
-
|
|
-
|
|
3,211
|
|
3,211
|
|
|
|
|
|
|
|
|
|
Balance - September
30, 2019
|
$
|
105,368
|
$
|
2,697
|
$
|
21,036
|
$
|
129,101
|
CHARLOTTE'S WEB
HOLDINGS, INC.
|
|
|
|
|
UNAUDITED INTERIM
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
|
(In thousands of
United States dollars)
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine months ended
September 30,
|
|
|
2019
|
2018
|
Cash flows from
operating activities:
|
|
|
|
|
|
Net income
|
$
|
3,211
|
$
|
8,656
|
Items not involving
cash:
|
|
|
|
|
|
Depreciation and
amortization
|
|
2,516
|
|
951
|
|
Change in fair value
of biological assets
|
|
(513)
|
|
1,622
|
|
Accretion on
convertible note
|
|
-
|
|
71
|
|
Change in fair value
of convertible note
|
|
-
|
|
(66)
|
|
Expected credit
losses
|
|
212
|
|
119
|
|
Inventory
reserve
|
|
1,536
|
|
181
|
|
Deferred
rent
|
|
(73)
|
|
(22)
|
|
Share-based
compensation
|
|
1,309
|
|
639
|
|
(Gain)/Loss on
disposal of fixed assets
|
|
8
|
|
(28)
|
|
Deferred income
taxes
|
|
(3,619)
|
|
(2,617)
|
|
|
|
|
|
|
Changes in working
capital:
|
|
|
|
|
|
Trade and other
receivables, net
|
|
(1,999)
|
|
(1,446)
|
|
Inventories
|
|
(33,451)
|
|
(11,391)
|
|
Prepaid expenses and
other current assets
|
|
(11,420)
|
|
(3,863)
|
|
Accounts
payable
|
|
696
|
|
2,727
|
|
Accrued
liabilities
|
|
13,768
|
|
3,494
|
|
Income
taxes
|
|
3,011
|
|
(104)
|
|
Deferred
revenue
|
|
17
|
|
(52)
|
|
Other long-term
liabilities
|
|
-
|
|
2,643
|
|
|
|
(24,791)
|
|
1,514
|
|
|
|
|
|
|
Cash flows from
investing activities:
|
|
|
|
|
|
Funding of note
receivable
|
|
(1,400)
|
|
-
|
|
Purchases of property
and equipment and intangibles
|
|
(10,806)
|
|
(2,503)
|
|
Proceeds from sale of
assets
|
|
53
|
|
38
|
|
Proceeds from related
party
|
|
21
|
|
-
|
|
Other investing
activities
|
|
(732)
|
|
313
|
|
|
|
(12,864)
|
|
(2,152)
|
|
|
|
|
|
|
Cash flows from
financing activities:
|
|
|
|
|
|
Proceeds from initial
public offering
|
|
-
|
|
71,958
|
|
Proceeds from private
placement
|
|
-
|
|
4,256
|
|
Proceeds from common
stock option exercise
|
|
695
|
|
-
|
|
Proceeds from stock
warrant exercise
|
|
486
|
|
1,782
|
|
Payments on notes
payable
|
|
(7)
|
|
(20)
|
|
Payments on lease
obligations
|
|
(1,943)
|
|
(226)
|
|
Payments on
convertible note
|
|
-
|
|
(1,000)
|
|
Debt
settlement
|
|
-
|
|
(45)
|
|
Share issuance
costs
|
|
-
|
|
(3,806)
|
|
Proceeds from sale of
common stock
|
|
-
|
|
42
|
|
|
|
(769)
|
|
72,941
|
|
|
|
|
|
|
|
Increase (decrease)
in cash
|
|
(38,424)
|
|
72,303
|
|
Cash, beginning of
year
|
|
73,404
|
|
7,056
|
|
Cash, end of
period
|
$
|
34,980
|
$
|
79,359
|
|
|
|
|
|
|
|
Supplemental
disclosures of cash flow information:
|
|
|
|
|
|
Cash paid for
interest
|
$
|
241
|
$
|
31
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/charlottes-web-holdings-reports-2019-q3-earnings-300957163.html
SOURCE Charlotte's Web Holdings, Inc.